跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,495 条关于
“Shanghai Henlius”
全部
1,495
临床试验
270
药物
529
机构
208
资讯
488
去年
FDA Approves Shanghai Henlius Biotech's Novel ALS Drug HLX99
去年
Henlius Receives Approval for HLX10 in China, Expanding Oncology Portfolio
去年
Shanghai Henlius Biotech Receives FDA Approval for Two Denosumab Biosimilars for Osteoporosis Treatment
去年
FDA Accepts Henlius' BLA for Denosumab Biosimilar HLX14 in Collaboration with Organon
去年
FDA Accepts BLA for Denosumab Biosimilar HLX14 Developed by Shanghai Henlius and Organon
10个月前
FDA Approves First Perjeta Biosimilar as Shanghai Henlius and Organon Secure Interchangeable Status
去年
Amgen Escalates Patent Defense with Three New Biosimilar Lawsuits Targeting Denosumab Competitors
去年
Henlius Biotech in Advanced Licensing Talks with J&J and Roche for Experimental Cancer Drug
去年
Henlius' Serplulimab Makes History as First PD-1 Inhibitor Approved in EU for Small Cell Lung Cancer
2个月前
Chinese Phase 3 Trial Shows Serplulimab-Based Regimen Reduces Gastric Cancer Recurrence Risk by 33% While Sparing Postoperative Chemotherapy
第 1 页,共 49 页
上一页
下一页